ARD-2128 is a highly potent, orally bioavailable PROTAC (proteolysis-targeting chimera) that degrades the androgen receptor (AR), effectively reducing AR protein levels, suppressing AR-regulated gene expression in tumor tissues, and inhibiting tumor growth without evident toxicity. This compound holds promise for prostate cancer research.
Molekulargewicht:
820.37
Reinheit:
98.80%
CAS Nummer:
[2222111-87-5]
Formel:
C45H50ClN7O6
Target-Kategorie:
Androgen Receptor|||PROTACs
T39695
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten